Fredrik Wallberg

London, ENG SW36JB, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.

Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.

Journal: British journal of cancer

Published: February 16, 2026

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Journal: Nature communications

Published: January 08, 2025

Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis.

Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis.

Journal: Nature communications

Published: October 30, 2024

3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.

3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.

Journal: Cancer research

Published: May 29, 2020

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids.

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids.

Journal: Journal for immunotherapy of cancer

Published: December 18, 2018

Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.

Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.

Journal: Cancer cell

Published: January 09, 2018

E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.

E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.

Journal: Cancer discovery

Published: May 30, 2017

Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.

Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.

Journal: British journal of cancer

Published: December 16, 2016

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells.

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells.

Journal: Scientific data

Published: July 05, 2016

Techniques to Distinguish Apoptosis from Necroptosis.

Techniques to Distinguish Apoptosis from Necroptosis.

Journal: Cold Spring Harbor protocols

Published: April 03, 2016

Analysis of Apoptosis and Necroptosis by Fluorescence-Activated Cell Sorting.

Analysis of Apoptosis and Necroptosis by Fluorescence-Activated Cell Sorting.

Journal: Cold Spring Harbor protocols

Published: April 03, 2016

Time-Lapse Imaging of Cell Death.

Time-Lapse Imaging of Cell Death.

Journal: Cold Spring Harbor protocols

Published: March 03, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026